Bionovo (BNVI) Reports Q3 Loss of $0.05
More News related to BNVI
- Bionovo (BNVI) Reports Q3 Loss of $0.05
- Bionovo Announces Third Quarter 2009 Highlights and Financial Results
- Steven R. Goldstein, M.D., Joins Bionovo's Menerba Medical Advisory Board
- Trading Radar for 11/05: Starbucks (SBUX), CBS Corp. (CBS), CVS (CVS), Toyota (TM), Thomson Reuters (TRI)
- Bionovo, Inc. to Announce Third Quarter Fiscal Year 2009 Financial Results on Thursday, November 5, 2009
More News related to Earnings
- Hoku Scientific (HOKU) Amends Poly Deal with Jinko Solar
- American International Group (AIG), Greenberg and Smith Settle Disputes
- Heska (HSKA) Announces Agreements with Roche for Blood Gas Product Supply/Affiliated Consumables
- AIG, Greenberg and Smith to settle all disputes
- DryShips (DRYS) Announces Exercise of Over-Allotment Option by Underwriters, Closes Convertible Senior Notes Offering for Net Proceeds of $448M
Bionovo Inc. (NASDAQ: BNVI) reports Q3 EPS of $0.05 loss, in-line analyst estimate of ($0.05). Revenue for the quarter was $155K
Related Categories
EarningsStocks Mentioned
+0.02Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
